International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

31 March 2015

Summary

 

IBT Portfolio NAV (m)

249

Number of Portfolio Companies

86

Quoted Investments

60

Unquoted Investments

26

 

Quoted / Unquoted Split
NAV by Geography

Quoted

93%

United States / Canada

90%

Unquoted

7%

Europe

10%

Total

100% 

Total

100%

 

 

 

 

 

NAV by Subsector
NAV by Market Capitalisation

 

 

Therapeutics

86%

Large-Cap (>$10bn)

61%

Medical Devices

3%

Mid-Cap (>$1bn, <$10bn)

16%

Specialty Pharma

10%

Small-Cap (<$1bn)

16%

Life Sciences, Tools

1%

Unquoted

7%

Total100%

Total

100%

 

 

NAV by Development Phase
NAV by Portfolio Profitability

 

 

 

Marketed

59%

Profitable

58%

Regulatory

13%

Turning Profitable 2014

6%

Phase 3

17%

Unprofitable

36%

Phase 2

7%

Total

100%

Phase 1

1%

 

Other

3%

 

Total

100%